Macrophages, Inflammation, and Lung Cancer

Lung cancer is the leading cause of cancer mortality worldwide, and at only 18%, it has one of the lowest 5-year survival rates of all malignancies. With its highly complex mutational landscape, treatment strategies against lung cancer have proved largely ineffective. However with the recent success...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of respiratory and critical care medicine 2016-01, Vol.193 (2), p.116-130
Hauptverfasser:	Conway, Emma M, Pikor, Larissa A, Kung, Sonia H Y, Hamilton, Melisa J, Lam, Stephen, Lam, Wan L, Bennewith, Kevin L
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers, Tumor - analysis Clinical Trials as Topic Disease Progression Humans Immunotherapy - methods Inflammation - etiology Lung cancer Lung Neoplasms - immunology Lung Neoplasms - mortality Lung Neoplasms - therapy Macrophages - immunology Phenotype Prognosis Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!